Taysha Gene Therapies Partners with Catalent to Boost Manufacturing

November 6, 2020

Dallas, Tex.-based Taysha Gene Therapies has teamed up with Catalent to bolster its manufacturing capability for adenovirus-based therapies.

Taysha, which is developing several gene therapies, said the company wants to establish a “robust infrastructure early” to ensure that it can provide gene therapies for thousands of patients.

Under the partnership, Catalent will supply increased production capacity from its five gene therapy facilities in Maryland.

View today's stories